255 related articles for article (PubMed ID: 26768001)
21. Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus.
Ferreira AF; Rezende JC; Vaikousi E; Akolekar R; Nicolaides KH
Clin Chem; 2011 Apr; 57(4):609-13. PubMed ID: 21325104
[TBL] [Abstract][Full Text] [Related]
22. Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes.
Mehmood S; Ye C; Connelly PW; Hanley AJ; Zinman B; Retnakaran R
Cardiovasc Diabetol; 2018 Oct; 17(1):133. PubMed ID: 30301460
[TBL] [Abstract][Full Text] [Related]
23. Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus.
Lekva T; Michelsen AE; Aukrust P; Henriksen T; Bollerslev J; Ueland T
Cardiovasc Diabetol; 2017 Jan; 16(1):5. PubMed ID: 28068986
[TBL] [Abstract][Full Text] [Related]
24. Predicting persistent impaired glucose tolerance in patients with gestational diabetes: The role of high sensitivity CRP and adiponectin.
Durnwald CP; Downes K; Leite R; Elovitz M; Parry S
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29078256
[TBL] [Abstract][Full Text] [Related]
25. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus.
Tsai PJ; Yu CH; Hsu SP; Lee YH; Huang IT; Ho SC; Chu CH
Nutrition; 2005; 21(11-12):1095-9. PubMed ID: 16308131
[TBL] [Abstract][Full Text] [Related]
26. Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus.
Hedderson MM; Darbinian J; Havel PJ; Quesenberry CP; Sridhar S; Ehrlich S; Ferrara A
Diabetes Care; 2013 Dec; 36(12):3930-7. PubMed ID: 23990523
[TBL] [Abstract][Full Text] [Related]
27. Glucose challenge test for detecting gestational diabetes mellitus: a systematic review.
van Leeuwen M; Louwerse MD; Opmeer BC; Limpens J; Serlie MJ; Reitsma JB; Mol BW
BJOG; 2012 Mar; 119(4):393-401. PubMed ID: 22260369
[TBL] [Abstract][Full Text] [Related]
28. [Correlation between the inflammatory factors and adipocytokines with gestational diabetes mellitus and their change in puerperium].
Liu T; Fang Z; Yang D; Liu Q
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):436-9. PubMed ID: 22932110
[TBL] [Abstract][Full Text] [Related]
29. Retinol-binding protein 4 (RBP4) circulating levels and gestational diabetes mellitus: a systematic review and meta-analysis.
Leca BM; Kite C; Lagojda L; Davasgaium A; Dallaway A; Chatha KK; Randeva HS; Kyrou I
Front Public Health; 2024; 12():1348970. PubMed ID: 38532976
[TBL] [Abstract][Full Text] [Related]
30. Detection of gestational diabetes mellitus by circulating plasma and serum microRNAs: A systematic review and meta-analysis.
Lazarus G; Dirjayanto VJ; Sambowo NB; Vianca E
Diabetes Metab Syndr; 2022 Jan; 16(1):102383. PubMed ID: 35016043
[TBL] [Abstract][Full Text] [Related]
31. Predicting gestational diabetes mellitus during the first trimester using anthropometric measurements and HOMA-IR.
Alptekin H; Çizmecioğlu A; Işık H; Cengiz T; Yildiz M; Iyisoy MS
J Endocrinol Invest; 2016 May; 39(5):577-83. PubMed ID: 26754418
[TBL] [Abstract][Full Text] [Related]
32. A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers.
Sweeting AN; Wong J; Appelblom H; Ross GP; Kouru H; Williams PF; Sairanen M; Hyett JA
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2122-2130. PubMed ID: 28562122
[TBL] [Abstract][Full Text] [Related]
33. Mild gestational diabetes in pregnancy and the adipoinsular axis in babies born to mothers in the ACHOIS randomised controlled trial.
Pirc LK; Owens JA; Crowther CA; Willson K; De Blasio MJ; Robinson JS
BMC Pediatr; 2007 Apr; 7():18. PubMed ID: 17430602
[TBL] [Abstract][Full Text] [Related]
34. Serum adipokines (adiponectin and resistin) correlation in developing gestational diabetes mellitus: pilot study.
Siddiqui K; George TP; Nawaz SS; Shehata N; El-Sayed AA; Khanam L
Gynecol Endocrinol; 2018 Jun; 34(6):502-506. PubMed ID: 29207892
[TBL] [Abstract][Full Text] [Related]
35. Screening and diagnosis of gestational diabetes in India: a systematic review and meta-analysis.
Li KT; Naik S; Alexander M; Mathad JS
Acta Diabetol; 2018 Jun; 55(6):613-625. PubMed ID: 29582160
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of circulating sex hormone-binding globulin for gestational diabetes: a meta-analysis.
Luo X; Cai WY; Song JY; Duan CC; Wu W; Man YJ; Wu XK; Xu J
Biomark Med; 2021 Aug; 15(12):1043-1053. PubMed ID: 34289735
[No Abstract] [Full Text] [Related]
37. Adipokines and macrophage markers during pregnancy-Possible role for sCD163 in prediction and progression of gestational diabetes mellitus.
Ueland T; Michelsen AE; Aukrust P; Henriksen T; Bollerslev J; Lekva T
Diabetes Metab Res Rev; 2019 Mar; 35(3):e3114. PubMed ID: 30548982
[TBL] [Abstract][Full Text] [Related]
38. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus.
Choi SH; Kwak SH; Youn BS; Lim S; Park YJ; Lee H; Lee N; Cho YM; Lee HK; Kim YB; Park KS; Jang HC
J Clin Endocrinol Metab; 2008 Aug; 93(8):3142-8. PubMed ID: 18492757
[TBL] [Abstract][Full Text] [Related]
39. [Effect of Plasma Lipids on GDM in the First Trimester of Pregnant Women: a Prospective Cohort Study].
Liu D; Wang Y; Li R; Dai ZY; Zhou R; Liu J; Zhang J; Zeng G
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 47(1):64-7, 72. PubMed ID: 27062784
[TBL] [Abstract][Full Text] [Related]
40. Correlation between atherogenic risk and adiponectin in gestational diabetes mellitus.
Matyjaszek-Matuszek B; Lenart-Lipińska M; Kowalczyk-Bołtuć J; Szlichtyng W; Paszkowski T
Ann Agric Environ Med; 2014; 21(1):143-7. PubMed ID: 24738514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
